Benefits of Dapagliflozin in Heart Failure Similar for Men, Women
WEDNESDAY, Nov. 16, 2022 -- Dapagliflozin is similarly beneficial for women and men with heart failure, according to a study published online Nov. 7 in Circulation.
Xiaowen Wang, M.D., from Harvard Medical School in Boston, and colleagues examined...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cardiology | Dapagliflozin | Forxiga | Harvard | Heart | Heart Failure | Pharmaceuticals | Study | Women